UPL
UPL
Chemicals F&OKey Fundamentals
MidcapPesticides & AgrochemicalsChemicalsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 24.4%
Weaknesses
3- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 6.02% over past five years.
- Company has a low return on equity of 1.87% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
UPL Ltd has a market capitalisation of about ₹46,248 Cr and trades at a P/E of 20 and a P/B of 1.34. Trailing-twelve-month sales grew 13% and profit grew 36%. Over 3 years, however, sales fell at a -1% CAGR, profit fell at a -21% CAGR, and ROE averaged about 2%. The stock has returned -15% over 1 year and -4% CAGR over 5 years, and the company has low interest coverage.
- TTM compounded profit growth of 36% suggests earnings are recovering after a 3-year profit CAGR of -21%.
- TTM sales growth of 13% is well above the 3-year sales CAGR of -1%, which points to a pickup in revenue.
- A P/B of 1.34 is modest relative to the company's 10-year average ROE of 10%, so the valuation already reflects a lot of the recent weakness.
- ROE improved to 6% last year from a 3-year average of about 2%, which suggests profitability is starting to normalise.
- The company has kept a dividend payout of 24.4% and offers a 1.09% dividend yield despite the earnings downturn.
- The 10-year sales CAGR of 14% shows the business has grown substantially over a full cycle.
- With a market cap of about ₹46,248 Cr, the company has the scale to benefit if margins recover.
- The 3-year average ROE of 1.87% is well below typical cost-of-equity levels, so the company has not been earning enough on shareholder capital.
- Profit has fallen at a 3-year CAGR of -21% and a 5-year CAGR of -10%, so earnings are still below levels from several years ago.
- Low interest coverage points to a heavy debt-servicing burden that could squeeze profits if earnings weaken again. Debt-to-equity data was not provided.
- The 5-year sales CAGR of 6.02% and 3-year sales CAGR of -1% show weak top-line momentum over the medium term.
- The stock has returned -15% over 1 year, -2% CAGR over 3 years, -4% CAGR over 5 years and only 2% CAGR over 10 years.
- A P/E of 20 is not low for a company whose last-year ROE was 6%. It assumes the TTM profit growth of 36% will last.
- The 36% TTM profit growth comes off a depressed base after a -21% 3-year profit CAGR, so it may partly be a cyclical rebound rather than lasting improvement.
- The 1.09% dividend yield offers limited income support compared with the stock's -15% 1-year return.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- COO Tamhane resigns from UPL Aug 26
UPL accepted Toshan Tamhane's resignation as Group COO, effective August 31, 2026. Tamhane, a former McKinsey executive, departs after 5.5 years to pursue entrepreneurial ventures.
TL;DR: Limited news flow for UPL this period, with the only development being a senior leadership departure. The COO's exit is planned well in advance (effective Aug 2026) and appears amicable, limiting immediate operational risk. Watch for a successor announcement and any broader management reshuffling in coming weeks.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,963 | 10,170 | 9,887 | 14,078 | 9,067 | 11,090 | 10,907 | 15,573 | 9,216 | 12,019 | 12,269 | 18,335 | 10,181 |
| Expenses | 7,747 | 9,049 | 9,820 | 12,230 | 7,998 | 9,873 | 9,229 | 12,409 | 7,820 | 10,072 | 10,033 | 14,854 | 8,814 |
| Operating Profit | 1,216 | 1,121 | 67 | 1,848 | 1,069 | 1,217 | 1,678 | 3,164 | 1,396 | 1,947 | 2,236 | 3,481 | 1,367 |
| OPM % | 14% | 11% | 0.7% | 13% | 12% | 11% | 15% | 20% | 15% | 16% | 18% | 19% | 13% |
| Other Income | 58 | 18 | 134 | 66 | 49 | 103 | 94 | -168 | 152 | 392 | 36 | 162 | 208 |
| Interest | 700 | 871 | 1,191 | 1,090 | 913 | 1,070 | 730 | 914 | 1,007 | 784 | 774 | 836 | 852 |
| Depreciation | 636 | 657 | 676 | 794 | 660 | 697 | 688 | 705 | 731 | 771 | 827 | 915 | 832 |
| PBT | -62 | -389 | -1,666 | 30 | -455 | -447 | 354 | 1,377 | -190 | 784 | 671 | 1,892 | -109 |
| Tax % | -265% | -25% | -4% | 367% | 16% | 31% | -141% | 22% | -7% | 22% | 27% | 32% | -33% |
| Net Profit | 102 | -293 | -1,607 | -80 | -527 | -585 | 853 | 1,079 | -176 | 612 | 490 | 1,294 | -73 |
| EPS in Rs | 1.97 | -2.24 | -14.41 | 0.47 | -4.55 | -5.25 | 9.81 | 10.61 | -1.04 | 6.56 | 4.7 | 12.57 | 0.12 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12,091 | 14,048 | 16,312 | 17,378 | 21,837 | 35,756 | 38,694 | 46,240 | 53,576 | 43,098 | 46,637 | 51,839 | 52,804 |
| Expenses | 9,728 | 11,700 | 13,346 | 13,966 | 18,024 | 28,984 | 30,342 | 36,711 | 43,380 | 38,801 | 39,509 | 42,761 | 43,773 |
| Operating Profit | 2,363 | 2,348 | 2,966 | 3,412 | 3,813 | 6,772 | 8,352 | 9,529 | 10,196 | 4,297 | 7,128 | 9,078 | 9,031 |
| OPM % | 20% | 17% | 18% | 20% | 17% | 19% | 22% | 21% | 19% | 10% | 15% | 18% | 17% |
| Other Income | -11 | 149 | 363 | 351 | -197 | -515 | 62 | 91 | 464 | 231 | 78 | 724 | 798 |
| Interest | 517 | 704 | 735 | 783 | 963 | 1,481 | 2,060 | 2,295 | 2,963 | 3,852 | 3,627 | 3,401 | 3,246 |
| Depreciation | 425 | 676 | 672 | 675 | 880 | 2,012 | 2,173 | 2,359 | 2,547 | 2,763 | 2,750 | 3,244 | 3,345 |
| PBT | 1,410 | 1,117 | 1,922 | 2,305 | 1,773 | 2,764 | 4,181 | 4,966 | 5,150 | -2,087 | 829 | 3,157 | 3,238 |
| Tax % | 17% | 15% | 10% | 12% | 11% | 21% | 16% | 11% | 14% | -10% | 1% | 30% | — |
| Net Profit | 1,187 | 952 | 1,733 | 2,030 | 1,575 | 2,178 | 3,495 | 4,437 | 4,414 | -1,878 | 820 | 2,220 | 2,323 |
| EPS in Rs | 15.82 | 13 | 20.18 | 23.57 | 17.35 | 20.66 | 33.4 | 42.18 | 42.28 | -14.21 | 10.62 | 22.78 | 23.95 |
| Div. Payout % | 19% | 23% | 20% | 20% | 27% | 26% | 27% | 21% | 21% | -6% | 53% | 26% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 86 | 86 | 101 | 102 | 102 | 153 | 153 | 153 | 150 | 150 | 159 | 169 |
| Reserves | 5,775 | 5,803 | 7,214 | 9,067 | 14,613 | 19,129 | 20,734 | 24,508 | 26,708 | 24,657 | 29,054 | 34,527 |
| Borrowings | 3,281 | 5,258 | 6,443 | 6,638 | 29,139 | 29,388 | 24,519 | 26,746 | 23,939 | 29,754 | 25,099 | 23,576 |
| Other Liabilities | 5,143 | 5,722 | 6,454 | 7,148 | 18,581 | 19,758 | 23,359 | 29,196 | 35,318 | 30,579 | 31,700 | 34,847 |
| Total Liabilities | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 86,012 | 93,119 |
| Fixed Assets | 4,031 | 3,862 | 4,071 | 4,437 | 32,149 | 35,321 | 34,765 | 36,193 | 38,713 | 39,056 | 39,084 | 42,153 |
| CWIP | 583 | 484 | 792 | 1,319 | 1,855 | 2,073 | 2,117 | 2,501 | 2,818 | 2,965 | 2,546 | 3,147 |
| Investments | 764 | 335 | 378 | 1,034 | 708 | 558 | 618 | 1,922 | 1,615 | 2,154 | 2,328 | 2,666 |
| Other Assets | 8,906 | 12,188 | 14,971 | 16,165 | 27,723 | 30,476 | 31,265 | 39,987 | 42,969 | 40,965 | 42,054 | 45,153 |
| Total Assets | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 86,012 | 93,119 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1,409 | 1,396 | 2,585 | 2,839 | 2,356 | 8,739 | 7,212 | 6,496 | 7,751 | 2,321 | 10,151 | 7,855 |
| Investing | -463 | -1,734 | -1,022 | -2,059 | -31,282 | -2,666 | -2,426 | -3,575 | -1,354 | -2,509 | -1,823 | -1,475 |
| Financing | -991 | 469 | 140 | -801 | 28,893 | -2,175 | -6,713 | -1,921 | -6,227 | 164 | -4,793 | -9,883 |
| Net Cash Flow | -45 | 131 | 1,703 | -21 | -33 | 3,898 | -1,927 | 1,000 | 170 | -24 | 3,535 | -3,503 |
| Free Cash Flow | 878 | 703 | 1,382 | 1,435 | 803 | 6,804 | 5,147 | 3,931 | 5,462 | 367 | 8,896 | 5,502 |
| CFO/OP | 71 | 78 | 99 | 90 | 71 | 141 | 95 | 79 | 88 | 81 | 156 | 93 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 115 | 133 | 127 | 127 | 195 | 121 | 115 | 121 | 124 | 138 | 121 | 126 |
| Inventory Days | 178 | 204 | 194 | 204 | 306 | 153 | 180 | 216 | 187 | 198 | 155 | 179 |
| Days Payable | 195 | 213 | 228 | 255 | 330 | 199 | 244 | 274 | 236 | 196 | 164 | 169 |
| Cash Conversion Cycle | 98 | 124 | 93 | 76 | 171 | 75 | 51 | 64 | 76 | 141 | 113 | 135 |
| Working Capital Days | 45 | 48 | 84 | 94 | 127 | 59 | 52 | 36 | 46 | 52 | 9 | 5 |
| ROCE % | 21% | 19% | 22% | 21% | 10% | 10% | 13% | 14% | 14% | 3% | 8% | 10% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view UPL insights
65 extracted metrics + investor summaries across FY07–FY27.
Documents
Frequently Asked Questions about UPL
What does UPL Ltd do?
Where is UPL Ltd (UPL) listed?
Which sector does UPL Ltd belong to?
What is the market capitalisation of UPL Ltd?
What is the PE ratio of UPL Ltd?
What is the 52-week high and low of UPL Ltd?
Does UPL Ltd pay dividends?
What is the Return on Equity (ROE) of UPL Ltd?
Company Information
UPL is principally engaged in the business of agrochemicals, industrial chemicals, chemical intermediates, speciality chemicals and production and sale of field crops and vegetable seeds.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/UPL.md for UPL Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.